RecruitingNCT04451265

Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

250 participants

Start Date

Oct 26, 2022

Study Type

OBSERVATIONAL

Conditions

Neuro-Ophthalmology

Summary

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MRI for people with neuro-ophthalmology. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMRI

Diffusion sequence (8 minutes long) added to the initial MRI

Locations(3)

CHU de LILLE

Lille, Lille, France

Fondation A De Rothschild

Paris, PARIS, France

Chu Rouen

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04451265

Related Trials

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

NCT07742878

Safety and Normative Data With Neos™

NCT072582123 locations